| Ticker | Company | Mkt Cap▼ | Price | Chg% | Volume |
|---|---|---|---|---|---|
| Alnylam Pharmaceuticals, Inc. | $41.9b | $331.43 | +3.9% | 556.5K | |
| Ionis Pharmaceuticals, Inc. Common Stock | $12.0b | $74.83 | +0.1% | 332.3K | |
| Arrowhead Research Corporation | $8.1b | $61.45 | +0.7% | 410.8K | |
| Wave Life Sciences Ltd. Ordinary Shares | $1.2b | $7.34 | +0.9% | 1.1M | |
| Atrium Therapeutics, Inc. Common Stock | $210.2m | $13.73 | +2.1% | 34.6K | |
| CAMP4 Therapeutics Corporation Common Stock | $207.7m | $4.46 | -0.2% | 35.7K | |
| ProQR Therapeutics N.V. Ordinary Shares | $159.1m | $1.81 | +6.1% | 583.5K | |
| Cartesian Therapeutics, Inc. Common Stock | $155.9m | $6.38 | +2.0% | 41.2K | |
| Exicure, Inc. Common Stock | $28.5m | $4.17 | -0.5% | 2.7K | |
| Phio Pharmaceuticals Corp. Common Stock | $13.9m | $1.25 | -1.9% | 97.6K |